Ling Ding
Impact in
-
- CAR-T cell therapy research
-
- Systemic Lupus Erythematosus Research
Papers in
-
- Sports Performance and Training 5
- Oncology 6
- CAR-T cell therapy research 5
- Co-authors
- Yue Zeng (1 shared paper)Junjie Fan (1 shared paper)Zhili Chen (4 shared papers)Shuo Zhang (1 shared paper)Jingjing Wang (1 shared paper)Xin Sui (1 shared paper)Lihong Lou (1 shared paper)Yingying Lu (1 shared paper)
- Journals
- Journal of Human Kinetics (2 papers)Frontiers in Nutrition (2 papers)Nutrition Metabolism and Cardiovascular Diseases (2 papers)Frontiers in Physiology (1 paper)Arthritis & Rheumatology (1 paper)
- Partner nations
- ChinaAustraliaUnited Kingdom
In The Last Decade
Ling Ding
29 papers receiving 327 citations
Ling Ding's Hit Papers
Peers
Comparison fields: 5 of 52
- Oncology 117
- Rheumatology 59
- Orthopedics and Sports Medicine 21
- Nephrology 22
- Immunology 24
Countries citing papers authored by Ling Ding
This map shows the geographic impact of Ling Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Ding more than expected).
Fields of papers citing papers by Ling Ding
This network shows the impact of papers produced by Ling Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Ding. The network helps show where Ling Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Ling Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial Hit paper breakdown → | 2024 | 155 |
| 2 | 2022 | 30 | |
| 3 | 2024 | 18 | |
| 4 | 2024 | 17 | |
| 5 | 2023 | 13 | |
| 6 | 2024 | 11 | |
| 7 | 2019 | 9 | |
| 8 | 2025 | 9 | |
| 9 | 2023 | 8 | |
| 10 | 2023 | 8 | |
| 11 | 2025 | 6 | |
| 12 | 2026 | 5 | |
| 13 | 2023 | 4 | |
| 14 | 2023 | 4 | |
| 15 | 2024 | 4 | |
| 16 | 2025 | 4 | |
| 17 | 2025 | 4 | |
| 18 | [Chemical constituents of Salvia chinensis]. | 2013 | 3 |
| 19 | 2023 | 3 | |
| 20 | 2024 | 3 |
About Ling Ding
Ling Ding is a scholar working on Orthopedics and Sports Medicine, Oncology, Rheumatology, Nephrology and Rehabilitation, having authored 32 papers that have together received 331 indexed citations. Recurring topics across this work include Sports Performance and Training (5 papers), CAR-T cell therapy research (5 papers), Systemic Lupus Erythematosus Research (4 papers), Lower Extremity Biomechanics and Pathologies (2 papers), Stroke Rehabilitation and Recovery (2 papers), Prenatal Screening and Diagnostics (2 papers), Gout, Hyperuricemia, Uric Acid (2 papers) and Neurobiology of Language and Bilingualism (2 papers). The work is most often cited by research in Oncology (117 citations), Rheumatology (59 citations), Orthopedics and Sports Medicine (21 citations), Nephrology (22 citations) and Immunology (24 citations). Ling Ding has collaborated with scholars based in China, Australia and United Kingdom. Frequent co-authors include Yue Zeng, Junjie Fan, Zhili Chen, Shuo Zhang, Jingjing Wang, Xin Sui, Lihong Lou, Yingying Lu, Bo Jiang and Qixiang Mei. Their work appears in journals such as Journal of Human Kinetics, Frontiers in Nutrition, Nutrition Metabolism and Cardiovascular Diseases, Frontiers in Physiology and Arthritis & Rheumatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.